Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 08:31 am Purchase |
2021-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
Nantahala Capital Management, LLC | 1,292 7.700% |
1,292 (New Position) |
Filing History |
| 2022-02-09 3:24 pm Sale |
2021-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
The Vanguard Group | 402 2.420% |
-433 (-51.83%) |
Filing History |
| 2022-02-09 3:24 pm Sale |
2021-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
VANGUARD INDEX FUNDS | 402 2.420% |
-343 (-46.04%) |
Filing History |
| 2021-02-12 5:20 pm Sale |
2020-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
Opaleye Management Inc. | 0 0.000% |
-920 (Position Closed) |
Filing History |
| 2021-02-10 10:39 am Purchase |
2020-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
The Vanguard Group | 835 5.610% |
835 (New Position) |
Filing History |
| 2021-02-08 10:37 am Purchase |
2020-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
VANGUARD INDEX FUNDS | 746 5.010% |
746 (New Position) |
Filing History |